Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
2.920
-0.050 (-1.68%)
At close: Jul 10, 2025, 4:00 PM
2.890
-0.030 (-1.03%)
After-hours: Jul 10, 2025, 4:04 PM EDT
IMDX Market Cap
IMDX has a market cap or net worth of $82.65 million as of July 10, 2025. Its market cap has increased by 118.66% in one year.
Market Cap
82.65M
Enterprise Value
55.10M
1-Year Change
118.66%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $82.65M, a decrease of -63.86%. That is a compound annual growth rate of -10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 84.90M | 111.72% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |